Replies to post #214 on Shockwave Medical Inc (SWAV)

[Whalatane]

Agree ...maybe they were hoping for higher reimbursement $ ?
General market sell off probably due to Fitch downgrade not helping
Earnings on Monday will be key ...other med tech Co's have reported strong earnings as use in operating rooms now back or above pre Covid levels .
JMO
Kiwi

[Whalatane]

Well your sale was looking well timed now :--)
Listening to the CC ....increase in operating expenses related to transferring to a direct sales team in EU countries and the Puerto Rico plant build out .
Not adding new accounts as fast as previously in the US
MD fees don't kick in to Jan 24
C2+ launch in Q4 ...in the US

Overall ....spending more $ , not growing as fast in the US , clinical trial in the Co they just bt is enrolling very slowly , income drivers more likely in Q4 and 2024.

Kiwi

[Whalatane]

Total operating expenses for Q2 2023 were $123.3 million, a 66% increase from 2022, primarily driven by sales force expansion, higher headcount, and acquisition-related expenses.

Kiwi